Results 211 to 220 of about 78,972 (322)

Y‐box binding protein 1 stabilizes EP300 mRNA and promotes forkhead box C1 H3K27Ac to aggravate chondrocyte injury in osteoarthritis

Journal of Cell Communication and Signaling, Volume 19, Issue 3, September 2025.
In this study, YBX1 binds to EP300 mRNA and enhances its stability and expression. Subsequently, EP300 binds to the FOXC1 promoter and promotes the enrichment of H3K27Ac at the FOXC1 promoter to elevate FOXC1 expression, ultimately regulating IL‐1β‐induced chondrocyte damage and promoting the progression of osteoarthritis.
Jingyi Li, Gang Zhou, Te Chen, Qiao Lin, Qiupeng Yang   +4 more
wiley   +1 more source

Establishment and characterization of a new human gallbladder cancer cell line, OCUG-2. [PDF]

World J Exp Med
Wang Q, Fan C, Tsujio G, Sakuma T, Maruo K, Yamamoto Y, Imanishi D, Kawabata K, Nishikubo H, Kanei S, Aoyama R, Kushiyama S, Ohira M, Yashiro M.   +13 more
europepmc   +1 more source

A STUDY ON SUBSEROSAL CANCER INFILTRATION AND PROGNOSIS IN RESECTED t2 GALLBLADDER CARCINOMAS

, 2003
Masashi Mizumoto, Shigeo Hisamori, Atsuko Yanagida, Hiroaki Maeda, Yoshito Asao, Hiroaki Furuyama, Yasuro Kato, Masaaki Awane, Tsunehiro Yoshimura, Satoru Nishimura, Yoshinori Nakamura, Satoru Matsusue   +11 more
openalex   +2 more sources

Two distinct pathways of p16 gene inactivation in gallbladder cancer [PDF]

, 2007
Hiroyuki Hiroyuki
openalex   +1 more source

Gallbladder cancer

, 2021
openaire   +1 more source

Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?

International Journal of Cancer, Volume 157, Issue 5, Page 964-979, 1 September 2025.
What's new? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart, Lars Tögel, Maria Giulia Carta, Philip Hetzner, Lina Helbig, Charlotte Zaglas, Maria Ziegler, Robert Stöhr, Annett Hölsken, Juliane Hoyer, Fulvia Ferrazzi, Clemens Neufert, Sebastian Lettmaier, Marianne Pavel, Henriette Golcher, Sarina K. Mueller, Florian Fuchs, Carla E. Schulmeyer, Matthias W. Beckmann, Bernd Wullich, Abbas Agaimy, Andre Reis, Arndt Hartmann, Norbert Meidenbauer, Silvia Spoerl, Florian Haller, Evgeny A. Moskalev   +26 more
wiley   +1 more source

Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review. [PDF]

Medicina (Kaunas)
Lau BSR, Chua NYM, Ong WT, Singh H, Luvira V, Takaori K, Shelat VG.   +6 more
europepmc   +1 more source

A CASE OF GALLBLADDER CANCER WITH A PSEUDOANEURYSM OF THE RIGHT HEPATIC ARTERY PRESENTED WITH BILIARY BLEEDING

, 2003
Hiroyuki Suzuki, Toshikazu Suwa, Sumio Yamashita, Norio Yasuda, Hideyuki Omoto, Fumihiko Ishikawa   +5 more
openalex   +2 more sources

Some Predictive Indexes Are Potentially Promising Clinical Parameters in Dogs with Primary Cholangitis‐Cholangiohepatitis

Veterinary Medicine and Science, Volume 11, Issue 5, September 2025.
The invasive nature of liver biopsy and the risk of complications make patients reluctant to undergo the procedure. This situation has necessitated the search for new markers to contribute to the clinical diagnosis and prognosis evaluation processes in dogs with cholangitis‐cholangiohepatitis.
Ekrem Çağatay Çolakoğlu, Melek Aydemir, Kadir Sevim, Ali Evren Haydardedeoğlu, Ufuk Kaya   +4 more
wiley   +1 more source

Role and mechanism of sarcosine dehydrogenase in the progression of gallbladder cancer through chemokine pathways. [PDF]

World J Gastrointest Oncol
Gao Z, Zhang X, He H.
europepmc   +1 more source